Skip to main content

Articles

Page 2 of 43

  1. To examine the impact of weight change on incident cardiovascular disease and coronary heart disease (CVD/CHD) among an Iranian population with type 2 diabetes mellitus (T2DM).

    Authors: Seyyed Saeed Moazzeni, Reyhane Hizomi Arani, Niloofar Deravi, Mitra Hasheminia, Davood Khalili, Fereidoun Azizi and Farzad Hadaegh

    Citation: Cardiovascular Diabetology 2021 20:141

    Content type: Original investigation

    Published on:

  2. The pleiotropic effects of statins may reduce the severity of COVID-19 disease. This study aims to determine the association between inpatient statin use and severe disease outcomes among hospitalized COVID-19...

    Authors: Prateek Lohia, Shweta Kapur, Sindhuri Benjaram, Zachary Cantor, Navid Mahabadi, Tanveer Mir and M. Safwan Badr

    Citation: Cardiovascular Diabetology 2021 20:140

    Content type: Original investigation

    Published on:

  3. Evidence from prospective cardiovascular (CV) outcome trials in type 2 diabetes (T2DM) patients supports the use of sodium–glucose co-transporter-2 inhibitors (SGLT2i) to reduce the risk of CV events. In this ...

    Authors: Jordi Real, Bogdan Vlacho, Emilio Ortega, Joan Antoni Vallés, Manel Mata-Cases, Esmeralda Castelblanco, Eric T. Wittbrodt, Peter Fenici, Mikhail Kosiborod, Dídac Mauricio and Josep Franch-Nadal

    Citation: Cardiovascular Diabetology 2021 20:139

    Content type: Original investigation

    Published on:

  4. To analyze incidence, use of therapeutic procedures, use of oral anticoagulants (OACs) and antiplatelet agents prior to hospitalization, and in-hospital outcomes among patients who were hospitalized with hemor...

    Authors: Ana Lopez-de-Andres, Rodrigo Jimenez-Garcia, Valentín Hernández-Barrera, Isabel Jiménez-Trujillo, José M. de Miguel-Yanes, David Carabantes-Alarcon, Javier de Miguel-Diez and Marta Lopez-Herranz

    Citation: Cardiovascular Diabetology 2021 20:138

    Content type: Original investigation

    Published on:

  5. The triglyceride-glucose (TyG) index is an alternative marker of insulin resistance (IR) and is closely associated with the prevalence and prognosis of atherosclerotic cardiovascular disease (ASCVD). However, ...

    Authors: Yong Zhu, Kesen Liu, Maolin Chen, Yan Liu, Ang Gao, Chengping Hu, Hong Li, Huagang Zhu, Hongya Han, Jianwei Zhang and Yingxin Zhao

    Citation: Cardiovascular Diabetology 2021 20:137

    Content type: Original investigation

    Published on:

  6. To compare left ventricular structure (LV) and diastolic function in young adults with youth- onset diabetes by type, determine the prevalence of abnormal diastolic function by diabetes type using published va...

    Authors: Amy S. Shah, Scott Isom, Dana Dabelea, Ralph D’Agostino Jr., Lawrence M. Dolan, Lynne Wagenknecht, Giuseppina Imperatore, Sharon Saydah, Angela D. Liese, Jean M. Lawrence, Cate Pihoker and Elaine M. Urbina

    Citation: Cardiovascular Diabetology 2021 20:136

    Content type: Original investigation

    Published on:

  7. Lower extremity amputations (LEA) are associated with a high mortality and medical expenditure. Diabetes accounts for 45% to 70% of LEA and is one of the most potent risk factors for peripheral artery diseases...

    Authors: Paola Caruso, Lorenzo Scappaticcio, Maria Ida Maiorino, Katherine Esposito and Dario Giugliano

    Citation: Cardiovascular Diabetology 2021 20:135

    Content type: Commentary

    Published on:

  8. Cross-sectional studies have reported that insulin resistance (IR) is associated with arterial stiffness. However, the relationship between IR and arterial stiffness progression remains unclear. This study aim...

    Authors: Zhiyuan Wu, Di Zhou, Yue Liu, Zhiwei Li, Jinqi Wang, Ze Han, Xinlei Miao, Xiangtong Liu, Xia Li, Wei Wang, Xiuhua Guo and Lixin Tao

    Citation: Cardiovascular Diabetology 2021 20:134

    Content type: Original investigation

    Published on:

  9. The prognostic importance of several hematological parameters has been scarcely investigated in type 2 diabetes. So, we aimed to evaluate their prognostic importance for development of complications in a cohor...

    Authors: Claudia R. L. Cardoso, Nathalie C. Leite and Gil F. Salles

    Citation: Cardiovascular Diabetology 2021 20:133

    Content type: Original investigation

    Published on:

  10. Myocardial fibrosis is a multistep process, which results in collagen deposition in the injured muscle. Empagliflozin, a sodium-glucose cotransporter 2 inhibitor (SGLT2i), decreases cardiovascular events risk....

    Authors: Elias Daud, Offir Ertracht, Nadav Bandel, Gassan Moady, Monah Shehadeh, Tali Reuveni and Shaul Atar

    Citation: Cardiovascular Diabetology 2021 20:132

    Content type: Original investigation

    Published on:

  11. This prospective study explored plaque morphology according to the underlying culprit lesion pathology (rupture versus erosion) in relation to the triglyceride glucose (TyG) index in patients with acute ST-ele...

    Authors: Xiaoxiao Zhao, Ying Wang, Runzhen Chen, Jiannan Li, Jinying Zhou, Chen Liu, Peng Zhou, Zhaoxue Sheng, Yi Chen, Li Song, Hanjun Zhao and Hongbing Yan

    Citation: Cardiovascular Diabetology 2021 20:131

    Content type: Original investigation

    Published on:

  12. Sodium-glucose co-transporter-2 inhibitors (SGLT-2is) are licenced for initiation for glucose lowering in people with type 2 diabetes (T2DM) with an estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73m2)...

    Authors: William Hinton, Michael D. Feher, Neil Munro, Mark Joy and Simon de Lusignan

    Citation: Cardiovascular Diabetology 2021 20:130

    Content type: Original investigation

    Published on:

  13. Sodium glucose co-transporter 2 inhibitors promote osmotic/natriuretic diuresis and reduce excess fluid volume, and this improves cardiovascular outcomes, including hospitalization for heart failure. We sought...

    Authors: Atsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, Yosuke Okada, Toshinari Takamura, Isao Taguchi, Shigeru Toyoda, Hirofumi Tomiyama, Shinichiro Ueda, Yukihito Higashi and Koichi Node

    Citation: Cardiovascular Diabetology 2021 20:105

    Content type: Original investigation

    Published on:

  14. Advanced glycation end-products are proteins that become glycated after contact with sugars and are implicated in endothelial dysfunction and arterial stiffening. We aimed to investigate the relationships betw...

    Authors: Anna Birukov, Rafael Cuadrat, Elli Polemiti, Fabian Eichelmann and Matthias B. Schulze

    Citation: Cardiovascular Diabetology 2021 20:110

    Content type: Original investigation

    Published on:

  15. To identify occupations where employees with type 2 diabetes have a high risk of cardiovascular disease (CVD) and mortality, and their prevalence of CVD risk factors. This study can contribute in the creation ...

    Authors: Sofia Carlsson, Tomas Andersson, Mats Talbäck and Maria Feychting

    Citation: Cardiovascular Diabetology 2021 20:129

    Content type: Original investigation

    Published on:

  16. The global burden of atrial fibrillation (AF) and diabetes mellitus (DM) is constantly rising, leading to an increasing healthcare burden of stroke. AF often remains undiagnosed due to the occurrence in an asy...

    Authors: Jakub Gumprecht, Gregory Y. H. Lip, Adam Sokal, Beata Średniawa, Katarzyna Mitręga, Jakub Stokwiszewski, Łukasz Wierucki, Aleksandra Rajca, Marcin Rutkowski, Tomasz Zdrojewski, Tomasz Grodzicki, Jarosław Kaźmierczak, Grzegorz Opolski and Zbigniew Kalarus

    Citation: Cardiovascular Diabetology 2021 20:128

    Content type: Original investigation

    Published on:

  17. ANGPTL8, an important regulator of lipid metabolism, was recently proven to have additional intracellular and receptor-mediated functions. This study aimed to investigate circulating levels of ANGPTL8 and its ...

    Authors: Huajie Zou, Yongping Xu, Xiaoyu Meng, Danpei Li, Xi Chen, Tingting Du, Yan Yang, Yong Chen, Shiying Shao, Gang Yuan, Xinrong Zhou, Shuhong Hu, Wentao He, Delin Ma, Junhui Xie, Benping Zhang…

    Citation: Cardiovascular Diabetology 2021 20:127

    Content type: Original investigation

    Published on:

  18. It remains unclear whether triglyceride-glucose (TyG) index, a surrogate marker of insulin resistance, is prospectively associated with incident peripheral arterial disease (PAD).

    Authors: Jing-Wei Gao, Qing-Yun Hao, Ming Gao, Kun Zhang, Xiong-Zhi Li, Jing-Feng Wang, Dominique A. Vuitton, Shao-Ling Zhang and Pin-Ming Liu

    Citation: Cardiovascular Diabetology 2021 20:126

    Content type: Original investigation

    Published on:

  19. In stable patients with type 2 diabetes (T2D), insulin treatment is associated with elevated risk for major adverse cardiovascular events (MACE). Patients with acute coronary syndrome (ACS) and T2D are at part...

    Authors: Gregory G. Schwartz, Stephen J. Nicholls, Peter P. Toth, Michael Sweeney, Christopher Halliday, Jan O. Johansson, Norman C. W. Wong, Ewelina Kulikowski, Kamyar Kalantar-Zadeh, Henry N. Ginsberg and Kausik K. Ray

    Citation: Cardiovascular Diabetology 2021 20:125

    Content type: Original investigation

    Published on:

  20. Type 2 diabetes mellitus (T2D) increases the risk of incident heart failure (HF), whose earliest fingerprint is effort intolerance (i.e. impaired peak oxygen consumption, or VO2peak). In the uncomplicated T2D pop...

    Authors: Lorenzo Nesti, Nicola Riccardo Pugliese, Paolo Sciuto, Nicolò De Biase, Matteo Mazzola, Iacopo Fabiani, Domenico Trico, Stefano Masi and Andrea Natali

    Citation: Cardiovascular Diabetology 2021 20:124

    Content type: Original investigation

    Published on:

  21. Diabetes has strongly been linked to atrial fibrillation, ischaemic heart disease and heart failure. The epidemiology of these cardiovascular diseases is changing, however, due to changes in prevalence of obes...

    Authors: Amy Groenewegen, Victor W. Zwartkruis, Betül Cekic, Rudolf. A. de Boer, Michiel Rienstra, Arno W. Hoes, Frans H. Rutten and Monika Hollander

    Citation: Cardiovascular Diabetology 2021 20:123

    Content type: Original investigation

    Published on:

  22. Disturbances of glucose metabolism can be diagnosed by an oral glucose tolerance test (OGTT) and by glycated haemoglobin (HbA1c). The aim of this study was to investigate the association between newly detected...

    Authors: Stelios Karayiannides, Catarina Djupsjö, Jeanette Kuhl, Claes Hofman-Bang, Anna Norhammar, Martin J. Holzmann and Pia Lundman

    Citation: Cardiovascular Diabetology 2021 20:122

    Content type: Original investigation

    Published on:

  23. Cardiac remodeling is one of the major risk factors for heart failure. In patients with type 2 diabetes, sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of the first hospitalization for heart...

    Authors: Yuze Zhang, Xiaoyan Lin, Yong Chu, Xiaoming Chen, Heng Du, Hailin Zhang, Changsheng Xu, Hong Xie, Qinyun Ruan, Jinxiu Lin, Jie Liu, Jinzhang Zeng, Ke Ma and Dajun Chai

    Citation: Cardiovascular Diabetology 2021 20:121

    Content type: Original investigation

    Published on:

  26. Information about the renin–angiotensin–aldosterone system (RAAS) in obese individuals before and after bariatric surgery is scarce. Aim of this study was to analyze the RAAS in severely obese subjects, in rel...

    Authors: Lucia La Sala, Elena Tagliabue, Elaine Vieira, Antonio E Pontiroli and Franco Folli

    Citation: Cardiovascular Diabetology 2021 20:118

    Content type: Original investigation

    Published on:

  28. Diabetes is associated with a significantly elevated risk of cardiovascular disease and its specific pathophysiology remains unclear. Recent studies have changed our understanding of cardiac cellularity, with ...

    Authors: Charles D. Cohen, Miles J. De Blasio, Man K. S. Lee, Gabriella E. Farrugia, Darnel Prakoso, Crisdion Krstevski, Minh Deo, Daniel G. Donner, Helen Kiriazis, Michelle C. Flynn, Taylah L. Gaynor, Andrew J. Murphy, Grant R. Drummond, Alexander R. Pinto and Rebecca H. Ritchie

    Citation: Cardiovascular Diabetology 2021 20:116

    Content type: Original investigation

    Published on:

  29. Prior studies in animal models showed that increased cardiac expression of TRIB3 has a pathogenic role in inducing left ventricular mass (LVM). Whether alterations in TRIB3 expression or function have a pathog...

    Authors: Gaia Chiara Mannino, Carolina Averta, Teresa Vanessa Fiorentino, Elena Succurro, Rosangela Spiga, Elettra Mancuso, Sofia Miceli, Maria Perticone, Angela Sciacqua, Francesco Andreozzi and Giorgio Sesti

    Citation: Cardiovascular Diabetology 2021 20:115

    Content type: Original investigation

    Published on:

  30. Carotid atherosclerosis represents one of the complications of diabetes mellitus. In particular, plaque instability contributes to disease progression and stroke incidence. High mobility group box-1 (HMGB1) is...

    Authors: Federico Biscetti, Giovanni Tinelli, Maria Margherita Rando, Elisabetta Nardella, Andrea Leonardo Cecchini, Flavia Angelini, Giuseppe Straface, Marco Filipponi, Vincenzo Arena, Dario Pitocco, Antonio Gasbarrini, Massimo Massetti and Andrea Flex

    Citation: Cardiovascular Diabetology 2021 20:114

    Content type: Original investigation

    Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2021 20:184

  31. Previous studies has shown a significant relationship between baseline triglyceride-glucose (TyG) index and subsequent cardiovascular disease (CVD). However, the effect of longitudinal changes in TyG index on ...

    Authors: Anxin Wang, Xue Tian, Yingting Zuo, Shuohua Chen, Xia Meng, Shouling Wu and Yongjun Wang

    Citation: Cardiovascular Diabetology 2021 20:113

    Content type: Original investigation

    Published on:

  32. In a recently published paper in Cardiovascular Diabetology, Sinha et al. (Association of fasting glucose with lifetime risk of incident heart failure: the Lifetime Risk Pooling Project. Cardiovasc Diabetol. 2021...

    Authors: Jian-di Wu, Dong-liang Liang and Yue Xie

    Citation: Cardiovascular Diabetology 2021 20:112

    Content type: Commentary

    Published on:

  33. The metabolic syndrome (MetS), defined by the simultaneous clustering of cardio-metabolic risk factors, is a significant worldwide public health burden with an estimated 25% prevalence worldwide. The pathogene...

    Authors: Mohamed A. Elhadad, Rory Wilson, Shaza B. Zaghlool, Cornelia Huth, Christian Gieger, Harald Grallert, Johannes Graumann, Wolfgang Rathmann, Wolfgang Koenig, Moritz F. Sinner, Kristian Hveem, Karsten Suhre, Barbara Thorand, Christian Jonasson, Melanie Waldenberger and Annette Peters

    Citation: Cardiovascular Diabetology 2021 20:111

    Content type: Original investigation

    Published on:

  34. Since 1985, the thiazolidinedione pioglitazone has been widely used as an insulin sensitizer drug for type 2 diabetes mellitus (T2DM). Although fluid retention was early recognized as a safety concern, data fr...

    Authors: Lorenzo Nesti, Domenico Tricò, Alessandro Mengozzi and Andrea Natali

    Citation: Cardiovascular Diabetology 2021 20:109

    Content type: Review

    Published on:

  35. Diabetes mellitus (DM) and depression are bidirectionally interrelated. We recently identified long-term trajectories of depression symptom severity in individuals with coronary heart disease (CHD), which were...

    Authors: Raphael S. Peter, Andrea Jaensch, Ute Mons, Ben Schöttker, Roman Schmucker, Wolfgang Koenig, Hermann Brenner and Dietrich Rothenbacher

    Citation: Cardiovascular Diabetology 2021 20:108

    Content type: Original investigation

    Published on:

  36. In a recent meta-analysis of randomized controlled trials of sodium glucose co-transporter 2 inhibitors (SGLT2i) in patients with diabetes, Lin and colleagues showed a positive association between SGLT2i-induc...

    Authors: Louis Potier, Kamel Mohammedi, Gilberto Velho and Ronan Roussel

    Citation: Cardiovascular Diabetology 2021 20:107

    Content type: Commentary

    Published on:

  37. Type 2 diabetes mellitus (DM) is one of the most common comorbidities among patients with heart failure (HF) with reduced ejection fraction (HFrEF). There are limited data regarding efficacy of hybrid comprehe...

    Authors: Renata Główczyńska, Ewa Piotrowicz, Dominika Szalewska, Ryszard Piotrowicz, Ilona Kowalik, Michael J. Pencina, Wojciech Zaręba, Maciej Banach, Piotr Orzechowski, Sławomir Pluta, Robert Irzmański, Zbigniew Kalarus and Grzegorz Opolski

    Citation: Cardiovascular Diabetology 2021 20:106

    Content type: Original investigation

    Published on:

  38. Metabolic syndrome (MetS) is an independent risk factor for the incidence of cardiovascular diseases. We investigated whether or to what extent MetS and its components was associated with coronary collateraliz...

    Authors: Tong Liu, Zheng Wu, Jinghua Liu, Yun Lv and Wenzheng Li

    Citation: Cardiovascular Diabetology 2021 20:104

    Content type: Original investigation

    Published on:

  39. Transferring results obtained in cardiovascular outcome trials (CVOTs) to the real-world setting is challenging. We herein transposed CVOT results to the population of patients with type 2 diabetes (T2D) seen ...

    Authors: V. Sciannameo, P. Berchialla, A. Avogaro and G. P. Fadini

    Citation: Cardiovascular Diabetology 2021 20:103

    Content type: Original investigation

    Published on:

  40. Women with type 2 diabetes are disproportionally affected by macrovascular complications; we here investigated whether this is also the case for microvascular complications and retinal microvascular measures.

    Authors: Rianneke de Ritter, Simone J. S. Sep, Carla J. H. van der Kallen, Marleen M. J. van Greevenbroek, Marit de Jong, Rimke C. Vos, Michiel L. Bots, Jos P. H. Reulen, Alfons J. H. M. Houben, Carroll A. B. Webers, Tos T. J. M. Berendschot, Pieter C. Dagnelie, Simone J. P. M. Eussen, Miranda T. Schram, Annemarie Koster, Sanne A. E. Peters…

    Citation: Cardiovascular Diabetology 2021 20:102

    Content type: Original investigation

    Published on:

  41. Several studies suggest that, together with glucose variability, the variability of other risk factors, as blood pressure, plasma lipids, heart rate, body weight, and serum uric acid, might play a role in the ...

    Authors: Antonio Ceriello and Francesco Prattichizzo

    Citation: Cardiovascular Diabetology 2021 20:101

    Content type: Review

    Published on:

  42. Cardiac arrhythmias are associated with poorer outcomes in patients with heart failure (HF), diabetes mellitus (DM), and chronic kidney disease (CKD). Previous studies have shown inconsistent conclusions regar...

    Authors: Hang-Long Li, Gregory Y. H. Lip, Qi Feng, Yue Fei, Yi-Kei Tse, Mei-zhen Wu, Qing-wen Ren, Hung-Fat Tse, Bernard-M. Y. Cheung and Kai-Hang Yiu

    Citation: Cardiovascular Diabetology 2021 20:100

    Content type: Original investigation

    Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2021 20:177

  43. About 50% of hospitalized coronavirus disease 2019 (COVID-19) patients with diabetes mellitus (DM) developed myocardial damage. The mechanisms of direct SARS-CoV-2 cardiomyocyte infection include viral invasio...

    Authors: Nunzia D’Onofrio, Lucia Scisciola, Celestino Sardu, Maria Consiglia Trotta, Marisa De Feo, Ciro Maiello, Pasquale Mascolo, Francesco De Micco, Fabrizio Turriziani, Emilia Municinò, Pasquale Monetti, Antonio Lombardi, Maria Gaetana Napolitano, Federica Zito Marino, Andrea Ronchi, Vincenzo Grimaldi…

    Citation: Cardiovascular Diabetology 2021 20:99

    Content type: Original investigation

    Published on:

  44. Metabolic syndrome certainly favors growth of carotid plaque; however, it is uncertain if it determines plaque destabilization. Furthermore, it is likely that only some components of metabolic syndrome are ass...

    Authors: Francesca Servadei, Lucia Anemona, Marina Cardellini, Manuel Scimeca, Manuela Montanaro, Valentina Rovella, Francesca Di Daniele, Erica Giacobbi, Iacopo Maria Legramante, Annalisa Noce, Rita Bonfiglio, Patrizia Borboni, Nicola Di Daniele, Arnaldo Ippoliti, Massimo Federici and Alessandro Mauriello

    Citation: Cardiovascular Diabetology 2021 20:98

    Content type: Original investigation

    Published on:

  45. Type 2 Diabetes is a major risk factor for cardiovascular (CV) mortality. Insulin resistance can be evaluated non-invasively by insulin sensitivity indices (ISI) such as the Mcauley index (MCAi), which is a fu...

    Authors: Yonatan Moshkovits, David Rott, Angela Chetrit and Rachel Dankner

    Citation: Cardiovascular Diabetology 2021 20:97

    Content type: Original investigation

    Published on:

  46. Increased risk of cardiovascular events is associated not only with dyslipidemias, but also with abnormalities in glucose metabolism and liver function. This study uses pooled analysis to explore the in-depth ...

    Authors: Koutaro Yokote, Shizuya Yamashita, Hidenori Arai, Eiichi Araki, Mitsunori Matsushita, Toshiaki Nojima, Hideki Suganami and Shun Ishibashi

    Citation: Cardiovascular Diabetology 2021 20:96

    Content type: Original investigation

    Published on:

  47. The association between glucose variability and the progression of atherosclerosis is not completely understood. We aimed to evaluate the associations of glucose variability with the progression of atheroscler...

    Authors: Naohiro Taya, Naoto Katakami, Tomoya Mita, Yosuke Okada, Satomi Wakasugi, Hidenori Yoshii, Toshihiko Shiraiwa, Akihito Otsuka, Yutaka Umayahara, Kayoko Ryomoto, Masahiro Hatazaki, Tetsuyuki Yasuda, Tsunehiko Yamamoto, Masahiko Gosho, Iichiro Shimomura and Hirotaka Watada

    Citation: Cardiovascular Diabetology 2021 20:95

    Content type: Original investigation

    Published on:

  48. Atherogenic dyslipidemia (AD), characterized by increased concentrations of apolipoprotein B (ApoB)-containing particles, is often present in individuals with type 2 diabetes mellitus (T2DM). Non-high-density ...

    Authors: Alberto J. Lorenzatti, Maria Laura Monsalvo, J. Antonio G. López, Huei Wang and Robert S. Rosenson

    Citation: Cardiovascular Diabetology 2021 20:94

    Content type: Original investigation

    Published on:

  49. Sodium–glucose cotransporter 2 inhibitor (SGLT2i) use reduces body weight (BW) in patients with type 2 diabetes mellitus (T2DM). Obesity and T2DM are strong risk factors of new-onset atrial fibrillation (AF). ...

    Authors: Yi-Hsin Chan, Shao-Wei Chen, Tze-Fan Chao, Yi-Wei Kao, Chien-Ying Huang and Pao-Hsien Chu

    Citation: Cardiovascular Diabetology 2021 20:93

    Content type: Original investigation

    Published on:

  50. To exam the associations between the use of sodium glucose co-transporter 2 inhibitor (SGLT2i) and the risk of lower limb complications, and to analyze the associated factors.

    Authors: Chu Lin, Xingyun Zhu, Xiaoling Cai, Wenjia Yang, Fang Lv, Lin Nie and Linong Ji

    Citation: Cardiovascular Diabetology 2021 20:91

    Content type: Original investigation

    Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2021 20:119

journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

Cardiovascular Diabetology

ISSN: 1475-2840